Vanguard VB vs. iShares ISCB: Evaluating Small-Cap ETF Strategies

Investors seeking exposure to the U.S. small-cap market often weigh the merits of the Vanguard Small-Cap ETF (VB) against the iShares Morningstar Small-Cap ETF (ISCB). While both provide broad diversification across more than 1,000 holdings, their underlying index methodologies result in distinct risk-return profiles and portfolio tilts. The primary distinctions lie in cost efficiency, liquidity, and sector concentration. VB tracks the CRSP US Small Cap Index and benefits from significant assets under management (AUM), whereas ISCB offers a different weighting strategy that may appeal to more conservative investors seeking lower volatility. VB maintains a cost advantage with a 0.03% expense ratio and a portfolio heavily weighted toward Industrials (20%) and Technology (16%). Its top positions include EMCOR Group, NRG Energy, and Atmos Energy. In contrast, ISCB features a 1.30% trailing 12-month dividend yield—surpassing VB's 1.20%—and focuses its allocations on Industrials (18%), Financial Services (16%), and Healthcare (14%). Key holdings for ISCB include Lumentum Holdings, Revolution Medicines, and Albemarle. From a trading perspective, VB's higher AUM provides superior liquidity for active participants. Furthermore, VB has demonstrated lower maximum drawdowns over a five-year horizon and stronger long-term capital appreciation, positioning it as a preferred vehicle for long-term buy-and-hold strategies.